weekly_bull_sm

Friday, Jan 4, 2019

News Recap:

Hepatitis B Treatment, Viread, Approved in USA for Children Under 12
Hepatitis B in children is of particular concern, as the younger a person is when she/he contracts HBV, the greater likelihood of developing the chronic form of the disease. While HBV vaccination (primarily of users of IV drugs, or of infants born to HBV+ mothers) remains the greatest HBV-related public health challenge for Canada, we also should consider the importance of treatment to our youngest victims of HBV.

HepCBC Gets Thank-You Letter from Federal Government Agency, CADTH
It’s been over a year since HepCBC sent CADTH its submission for Vosevi (sofosbuvir / velpatasvir / voxilaprevir) for hepatitis C infection. In their thank-you letter to HepCBC, CADTH explained how its patient input had helped them in making their decisions (to recommend) Vosevi:

Update: Memorial Dinner will Honour Phil Wilkin at Our Place next Thursday, January 10th
400-500 community guests are expected to attend a complimentary dinner in honour of HepCBC Board Member, Phil Wilkin, at Our Place (919 Pandora Avenue, Victoria, BC) on Thursday, January 10th from 5 pm – 6 pm. Phil passed away unexpectedly of sudden cardiac arrest on November 24th. HepCBC, with Our Place’s great help, is organizing this dinner, both in raising the funds ($800) and getting volunteers to help with serving and cleanup.